These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 3954247

  • 1. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease.
    Dal Nogare AR, Rubin LJ.
    Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247
    [Abstract] [Full Text] [Related]

  • 2. Effects of hydralazine on hemodynamics, ventilation, and gas exchange in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Keller CA, Shepard JW, Chun DS, Dolan GF, Vasquez P, Minh VD.
    Am Rev Respir Dis; 1984 Oct; 130(4):606-11. PubMed ID: 6486560
    [Abstract] [Full Text] [Related]

  • 3. Effects of hydralazine on mouth occlusion pressure and ventilatory response to hypercapnia in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Corriveau ML, Shepard JW, Dolan GF.
    Am Rev Respir Dis; 1987 Jan; 135(1):118-22. PubMed ID: 3800141
    [Abstract] [Full Text] [Related]

  • 4. Detrimental effects of hydralazine in patients with chronic air-flow obstruction and pulmonary hypertension. A combined hemodynamic and radionuclide study.
    Tuxen DV, Powles AC, Mathur PN, Pugsley SO, Campbell EJ.
    Am Rev Respir Dis; 1984 Mar; 129(3):388-95. PubMed ID: 6322627
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hemodynamic effects of vasodilators on pulmonary hypertension in decompensated chronic obstructive pulmonary disease.
    Cerdá E, Esteban A, de la Cal MA, Fernández A, García A.
    Crit Care Med; 1985 Apr; 13(4):221-3. PubMed ID: 3979067
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S, Andrivet P, Piquet J, Brun-Buisson C, Rauss A, Bignon J, Lemaire F.
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J, Gomez A, Sandoval J, Barrios R, Martinez W.
    Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hemodynamic effect of hydralazine in advanced, stable chronic obstructive pulmonary disease with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E, Seoane M, Verdejo J.
    Chest; 1984 Feb; 85(2):156-63. PubMed ID: 6692695
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of urapidil in patients with pulmonary hypertension. A comparative study with hydralazine.
    Adnot S, Defouilloy C, Brun-Buisson C, Abrouk F, Piquet J, Lemaire F.
    Am Rev Respir Dis; 1987 Feb; 135(2):288-93. PubMed ID: 3813189
    [Abstract] [Full Text] [Related]

  • 16. [Pulmonary hypertension and chronic obstructive ventilatory disorders--correlation between hemodynamic parameters and pulmonary function].
    Gassner A, Tizek H, Fridrich L, Pichler M.
    Schweiz Med Wochenschr; 1985 Feb 23; 115(8):266-72. PubMed ID: 3983597
    [Abstract] [Full Text] [Related]

  • 17. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ, Peter RH.
    N Engl J Med; 1980 Jan 10; 302(2):69-73. PubMed ID: 7350435
    [Abstract] [Full Text] [Related]

  • 18. [The effects of diltiazem on pulmonary hemodynamics and oxygenation in copd induced pulmonary hypertension].
    Fang B, Wang C, Dai H.
    Zhonghua Yi Xue Za Zhi; 1998 Oct 10; 78(10):779-81. PubMed ID: 11038835
    [Abstract] [Full Text] [Related]

  • 19. Vasodilatory treatment of pulmonary hypertension.
    Widimský J.
    Eur J Respir Dis; 1986 Mar 10; 68(3):161-6. PubMed ID: 2870937
    [Abstract] [Full Text] [Related]

  • 20. Long-term effects of hydralazine on ventilation and blood gas values in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Corriveau ML, Vu-Dinh Minh, Dolan GF.
    Am J Med; 1987 Nov 10; 83(5):886-92. PubMed ID: 3674095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.